Results 91 to 100 of about 695,475 (255)

Neurocognitive, School‐Based, and Quality of Life Outcomes for Youth With Sickle Cell Disease and Thalassemia: A Scoping Review

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT The medical burdens of sickle cell disease (SCD) and transfusion‐dependent β‐thalassemia (TDT) are chronic and cumulative, even in children. Yet the effects expand beyond medications and healthcare visits due to their impacts on school attendance, academic performance, and peer engagement.
Mary Ann Etling   +2 more
wiley   +1 more source

Antibiotic prescribing trends and outcomes in outpatient low-risk diverticulitis: a retrospective analysis in Veterans Health Administration between 2016 and 2023

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology
Background: Outpatient antibiotic prescribing remains common despite evidence that selective non-antibiotic management is safe for low-risk uncomplicated diverticulitis.
Shinya Hasegawa   +3 more
doaj   +1 more source

Representation of Sickle Cell Disease Patients in Pediatric and Adult Care: What We Discovered Using Informatics for Integrating Biology and the Bedside (i2b2) Data

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Transitioning from pediatric to adult care is a high‐risk period for individuals with sickle cell disease (SCD). An initial observation at one academic medical center suggested a sex‐based disparity in clinic populations, prompting a national investigation.
Laurie J. Duckworth   +5 more
wiley   +1 more source

Understanding the evaluation of access and participation outreach interventions for under 16 year olds [PDF]

open access: yes, 2018
The project team was asked to address the following six research questions and these were used to guide the project: 1. What are the intended outcomes for current outreach interventions directed at under 16 year olds from disadvantaged backgrounds where ...
Harrison, Neil   +6 more
core  

Lorlatinib‐Containing Therapy for MYCN‐Amplified, ALK‐Mutated Neuroblastoma With Bulky Leptomeningeal Relapse: A Case Report

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Central nervous system (CNS) relapse of neuroblastoma carries a poor prognosis, and craniospinal irradiation (CSI) poses substantial long‐term toxicity in young children. We report a toddler with MYCN‐amplified neuroblastoma harboring somatic ALK R1275Q who developed extensive leptomeningeal relapse with paraplegia.
Jinwoo Kim   +11 more
wiley   +1 more source

Variation in facility-level likelihood of drug-resistant Staphylococcus aureus in outpatients remains after patient-level risk adjustment

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology
Objective: Effective empiric therapy options for Staphylococcus aureus infections are limited by rising rates of resistance to non-beta lactam antimicrobial agents.
Margaret Carrel   +5 more
doaj   +1 more source

Uncovering Inequities: The Role of Social Determinants of Health in Hospitalized Adolescents and Young Adults With Heavy Menstrual Bleeding

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Heavy menstrual bleeding (HMB) is a common condition among adolescents and young adults (AYAs) and is the leading cause of iron deficiency anemia (IDA) in this population. Growing evidence suggests that social determinants of health (SDOH) influence menstrual bleeding patterns, access to care, and treatment. However, no studies have
Maria Carter‐Febres   +6 more
wiley   +1 more source

Providing collateral and improving product market access for smallholder farmers: a randomized evaluation of inventory credit in Sierra Leone

open access: yes
The title of the project was: "Providing collateral and improving product market access for smallholder farmers: a Randomized evaluation of inventory credit in Sierra Leone.
Prof Tavneet Suri
core   +1 more source

NoMachine Remote Access Evaluation Report [PDF]

open access: yes, 2016
The Technology Investigation Service's Technology Evaluation team conducted an evaluation of the NoMachine remote desktop tool. This report summarizes their findings.Submitted by Janet Brown (brown@psc.edu) on 2016-06-30T20:37:09Z No.
The Technology Investigation Service's Technology Evaluation Team
core  

Recommended Phase 2 Dose for Abemaciclib in Combination With Temozolomide in Pediatric and Young Adult Patients With Relapsed/Refractory Solid Tumors: Results From Study JPCS Part B

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Cyclin‐dependent kinase 4/6 (CDK4/6) pathway aberrations, including CDK4 or CCND1 amplification, CDKN2A/B loss, retinoblastoma (RB) dysregulation, and cyclin D overexpression, are relevant for pediatric cancers. Abemaciclib, a selective CDK4/6 inhibitor with preferential CDK4 activity and central nervous system (CNS) penetration ...
Alvaro Lassaletta   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy